HomeTVRD โข NASDAQ
add
Tvardi Therapeutics Inc
Previous close
$2.96
Day range
$2.83 - $2.98
Year range
$2.75 - $43.65
Market cap
27.21M USD
Avg Volume
53.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | โ | โ |
Operating expense | 7.59M | -29.76% |
Net income | -7.28M | 42.75% |
Net profit margin | โ | โ |
Earnings per share | -0.78 | โ |
EBITDA | -7.56M | 29.83% |
Effective tax rate | โ | โ |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.81M | -2.54% |
Total assets | 32.07M | -8.88% |
Total liabilities | 11.13M | -72.75% |
Total equity | 20.95M | โ |
Shares outstanding | 9.38M | โ |
Price to book | 1.33 | โ |
Return on assets | -53.36% | โ |
Return on capital | -77.04% | โ |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -7.28M | 42.75% |
Cash from operations | -5.68M | -17.63% |
Cash from investing | 5.00M | โ |
Cash from financing | 1.00K | -100.00% |
Net change in cash | -684.00K | -103.08% |
Free cash flow | -3.11M | -665.51% |
About
Founded
2017
Headquarters
Website
Employees
12
